Do These Marijuana Stocks Offer Investors Real Value
When choosing the best marijuana stock to buy there are some things you need to know. For instance, if you’re new to investing specifically with stocks then doing proper research is a must. How can you plan to make any return if you don’t know how the market works. This is no different when searching for marijuana stocks to watch. Or any stock for that matter. Understanding the market takes a great deal of time and effort. However, if you dedicate enough time to it you will begin to have an understanding of how the market works. Once you educate yourself on how the stock market works next is researching the industry you want to invest in.
Currently a lot of investors new or old are focusing on the cannabis industry. Some analysts say with nationwide cannabis reform a possible new green rush is on the way. If this does happen in the near future MSO and pure-play marijuana stocks will be the players to watch. Why you ask? because pure-play marijuana stocks like Harvest Health & Recreation Inc (HRVSF Stock Report) work with cultivating cannabis which is needed to run the entire industry. No cannabis no business.
Marijuana Stock Info
The value with MSO marijuana stocks is a company like Curaleaf Holdings Inc (CRLBF Stock Report) can operate in different regions that have an existing cannabis industry. Cannabis companies like these are what most investors typically look for. This is because they show the most growth potential in a volatile market. So when deciding on which top marijuana stocks to add to your portfolio go through the steps above and take your time. Below we will discuss the growth potential of 2 pot stocks to watch heading into 2021.
Marijuana Stock Watchlist
A Cannabis Stock To Buy or Sell: TILT Holdings Inc. (TLLTF)
TILT Holdings Inc. may not be a cannabis stock you hear a lot about. However, the company has made some progress in the industry. TILT Holdings is essentially a tech company that helps build cannabis brands across 35 states. The company focuses on providing technology, hardware, cultivation, and production services for cannabis businesses. Over the last few weeks, TLLTF stock has dropped in value going from 0.42 a share to a current price of 0.29. However, the company did post some positive results from its recent Q3 report.
The company saw a 5% increase in revenue in comparison to its Q2 of 2020 for a total of $40.4 million. They also posted a positive adjusted EBITDA for the third consecutive quarter at $2.8 million. In recent news, TILT Holdings announced they have completed the sale of Blackbird. Yaris Acquisition, LLC, or Blackbird is a distribution company that offers logistics operations for each touchpoint in the cannabis supply chain.
“Jupiter, Commonwealth Alternative Care, and Standard Farms are all synergistic, cashflow positive businesses with ample runway for reinvestment and future growth and now is the right time to give them the additional resources they need,” said Gary Santo, President of TILT.
With much in the works, this may be what TLLTF stock needs to see a bounce in the near future. Especially with many new ventures unfolding in the cannabis industry. I seem like cathing a wave of momentum may happen if things continue to progress for the company. For now, investors are keeping an eye on this marijuana stock as more things develop for the company.
A Cannabis Stock To Buy or Sell: GW Pharmaceuticals plc (GWPH)
GW Pharmaceuticals plc is a well-known marijuana stock to watch in the market. Some investors have hedged their bets on the progress the company has had. This largely due to its flagship product Epidiolex which is used to treat rare forms of epilepsy. The company works with the production of cannabinoids to create innovative therapies for various ailments. However, a great deal of the company’s revenue is generated with Epidiolex. In recent news, Greenwich Biosciences, a subsidiary of GW Pharmaceuticals will present information on Epidiolex. This data comes from extensive research and trials. Greenwich Biosciences will be presenting this data on Epidiolex at the American Epilepsy Society Annual Meeting.
This presentation holds great value for those who are not familiar with the benefits Epidilaex has. Especially with those who work in the medical field looking for alternative treatments for epilepsy. For the month of November, GWPH stock shot up 56% all things considered this a substantial gain. As GW Pharmaceuticals continues with cannabinoid research the medical world should focus on the positive impact CBD has had. So as we prepare for the new year many investors will keep this pot stock on their watchlist for further developments.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | firstname.lastname@example.org